Bismuth subcitrate potassium / Metronidazole / Tetracycline hydrochloride

Key facts

Active substance
  • Bismuth subcitrate potassium
  • Metronidazole
  • Tetracycline hydrochloride
Therapeutic area
Gastroentology-Hepatology
Decision number
P/74/2009
PIP number
Bismuth subcitrate potassium / Metronidazole / Tetracycline hydrochloride
Pharmaceutical form(s)
Capsule
Condition(s) / indication(s)
Helicobacter pylori infection
Route(s) of administration
Oral use
Contact for public enquiries
Axcan Pharma SA
E-mail: cboudes@axcan.com
Country: France
Phone: +33 130461916
Fax: +33 130466547
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

Topics

How useful was this page?

Add your rating